Spain
Kymos Group, founded in 2001, operates as an analytical CRO specializing in bioanalysis and CMC services for diverse chemical entities like small molecules, biologics, and nucleic acids. Firmly rooted in the biotechnology and pharmaceutical industries, they cater to multiple sectors including veterinary, fine chemistry, cosmetics, and nutraceuticals.
Headquartered in Spain, Kymos Group boasts two facilities within the Cerdanyola del Vallès Technology Park, complemented by additional laboratories in Italy and Germany. Their laboratories are outfitted with cutting-edge technology, ensuring comprehensive services ranging from bioequivalence studies to complex nucleic acid bioanalysis.
Kymos Group is GMP and GLP certified, with successful inspections by both the EMA and FDA. Contemporary needs in bioanalysis and quality control are met through strategic partnerships and collaborations, underscoring their robust international footprint. Currently, they seek to expand their operational capabilities through potential investments, offering lucrative opportunities in a steadily growing market segment.
